Showing results (371-380 of 489) with videos related to

Sort By:
Pageof 49
The European Respiratory Journal|May 16, 2009
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsC Crim, P M A Calverley, J A Anderson, et al.
Thorax|August 26, 2009
Adherence to inhaled therapy, mortality and hospital admission in COPDJ Vestbo, J A Anderson, P M A Calverley, et al.
Neuroscience|December 24, 2019
Long-term Exercise Confers Equivalent Neuroprotection in Females Despite Lower Cardiorespiratory FitnessChristopher J Marley, Julien V Brugniaux, Danielle Davis, et al.
ERJ Open Research|November 25, 2021
Impact of the UK lockdown on people at risk of COPDGavin C Donaldson, Andrew I Ritchie, Peter M A Calverley, et al.
Respiratory Medicine|May 18, 2010
Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohortMartijn A Spruit, Michael L Watkins, Lisa D Edwards, et al.
Chest|February 16, 2013
Cardiovascular safety in patients receiving roflumilast for the treatment of COPDWilliam B White, Glen E Cooke, Peter R Kowey, et al.
Experimental Physiology|October 29, 2023
Acute hypoxia impairs posterior cerebral bioenergetics and memory in manSoichi Ando, Hayato Tsukamoto, Benjamin S Stacey, et al.
American Journal of Respiratory and Critical Care Medicine|September 4, 2010
Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experienceBartolome Celli, Jörgen Vestbo, Christine R Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|May 31, 2008
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyBartolomé R Celli, Nicola E Thomas, Julie A Anderson, et al.
Respiratory Medicine|November 20, 2020
Use of mucolytics in COPD: A Delphi consensus studyAlberto Papi, Sergey Avdeev, Peter M A Calverley, et al.
Pageof 49